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Hallgren, R., and Wide, L. (1976) . Annals of the Rheumatic Diseases, 35, 306-313. Detection of circulating IgG aggregates and immune complexes using 1251 protein A from Staphiococcus aureus. A method for detection of circulating immune complexes by the use of 125I labelled staphylococcal protein A is described. In a polyethylene glycol solution as little as 1-2 mg/l of soluble heat aggregated human IgG could be quantitated.
Variables which might influence the assay were examined. Separation of immune complexes in serum from monomeric IgG was essential and achieved by gel chromatography on Sephadex G200. This assay may be suitable for clinical routine for detection and quantitation of immune complexes. A preliminary study on the clinical application of the method is presented. 58 % of patients with systemic lupus erythematosus and 42 % of patients with rheumatoid arthritis had increased levels of immune aggregates in serum compared to a group of healthy individuals.
Circulating immune complexes are known to play a role in a variety of immunopathological processes in man. Animal experiments have contributed to the understanding of the elimination of immune complexes and of the pathogenesis of glomerular and vascular lesions induced by tissue deposition of such complexes (Cochrane and Koffler, 1973) . The presence of circulating immune aggregates depends on the balance between rate of formation and removal of complexes by the reticuloendothelial system. The size of the complexes is important in this context. For example, immune complexes greater than 19S are quickly removed from the circulation of rabbits, mainly by the liver, while smaller antigen-antibody complexes remain longer in the circulation (Cochrane and Hawkins, 1968) . Several approaches have been used to show immune complexes in sera and tissues.
Immune aggregates in sera from patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis have been detected by analytical ultracentrifugation (Kunkel and others, 1961) and biological techniques such as histamine release (Baumal and Broder, 1968) and platelet aggregation (Wager and others, 1973) . Circulating immune aggregates have been found in sera from patients with SLE and other hypocomplementaemic states (Agnello and others, 1971) , dermatitis herpetiformis (Mowbray and others, 1973) , leprosy (RojasEspinosa, Mendez-Navarrate, and Estrada-Parra, 1972) , and polyarteritis nodosa (Gocke and others, 1971) by agar gel precipitation with Clq. Isolated rheumatoid factors have also been used to detect soluble complexes . A simple, sensitive, and specific method is not currently available for detecting immune complexes. This paper describes in detail a new method for the detection of circulating IgG aggregates and immune complexes based on the large molecular size of immune complexes and the binding properties of protein A of Staphylococcus aureus (SpA) to the Fc-part of IgG (Forsgren and Sj6quist, 1966) . Variables which might influence the assay procedure have been examined. A preliminary study on the clinical application of the method is also presented.
Materials
Assay buffer was made up of 500 ml 0 1 mol/l phosphate buffer pH 7 -5, 500 ml 0 * 9 % (w/v) NaCl, 10 ml 5 % (w/v) NaN3, 5 ml tween-20 and 5 ml 20% human serum albumin (Kabi, Sweden (Sjoquist, Meloun, and Hjelm, 1972) . Human IgG was supplied by AB Kabi. Heat aggregation was performed for 20 min at 63°C in a 2% IgG solution.
The aggregates (agg lgG) were separated from the monomeric IgG (mon IgG) by gel filtration on a 90 x 1*5 cm column of Sephadex G200 (Pharmacia AB, Uppsala, Sweden) equilibrated with 0 1 mol/l TRIS-HCI, pH 8 0, containing 0 5 mol/l NaCl. Concentrations of agg IgG were determined spectrophotometrically at 280 nm.
Clq was prepared from fresh human serum according to the method of Shelton, Yonemasu, and Stroud (1972) . Purity was shown by immunoelectrophoresis using antihuman total serum and anti-Clq serum (Behringwerke AB, W. Germany). Concentrations of Clq were determined spectrophotometrically using the extinction coefficient of 6-8 at 278 nm (Yonemasu and others, 1971 SpA-PEG PROCEDURE) 200 V1 of the sample to be tested + 200 ,ul of the PEGassay buffer + 100 , l of 1251 SpA (40 000 cpm) diluted in the assay buffer were put into disposable plastic test tubes which were then sealed with a plastic cap and placed in racks attached to a Heto Rotamix. They were rotated for 16 hours at 4°C, after which all tubes were removed from the rack and centrifuged at 3500 g for 5 minutes. The plastic plugs were carefully removed. 1 ml of a saline solution with 0 5% tween-20 was added to each tube with an automatic pipetting machine and the tubes were again centrifuged at 3500 g for 5 minutes. The supernatant was removed by suction using a modified syringe needle attached to a plastic plate to prevent the needle from removing more than the desired amount of the supernatant. The washing cycle was repeated three times more. The tubes were sealed with plastic caps and placed in the automatic gamma counter. To test the amount of immune complexes in serum, mon IgG was separated from the macromolecular IgG aggregates by gel filtration. A number of small columns were operated in parallel, as described above (gel chromatography B) giving a high capacity of the gel filtration procedure. The void volume containing immune aggregates was heat-inactivated at 56°C for 30 minutes before assayed according to the 1251 SpA-PEG procedure. All samples were run in duplicate. As a laboratory standard for calibration, different amounts of agg IgG were mixed with the heat inactivated first peak (diluted to give an OD 280 of 0 3) of pooled normal sera fractionated on a G200 to give a standardized protein solution. Agg IgG and the standard protein solution were frozen in small samples at-20°C and thawed on the day to be used. In order to study these influences a normal serum without rheumatoid factor activity was investigated in the following manner. Serial dilutions of the serum were tested according to the 125I SpA-PEG procedure. There was no 125I SpA precipitation activity in any serum dilution as shown in Fig. 2 . By addition of agg IgG to a final concentration of 20 mg/l to each serum dilution no precipitation was obtained in undiluted serum. The suppression of 125I SpA precipitation by serum was significant even at a serum dilution of 1/125 (Fig. 2 ). The detection of circulating immune complexes by the use of 125I SpA was limited by different serum factors, and the need to separate the macromolecular immune aggregates from mon IgG to obtain adequate results was evident. Sera from 5 patients with active SLE and 5 healthy volunteers were separated on a Sephadex G200 (1 5 x 90 cm) column. Each fraction was analysed according to the 1251 SpA-PEG procedure. Quite a different precipitating pattern was obtained in these two groups. The serum from 3 of the 5 SLE patients produced a heavy precipitation of 125I SpA in the macromolecular region (Fig. 6 ). This precipitation profile is not obtained with sera from normal healthy individuals. The amount of 1251 SpA precipitated in Fig. 6 described a doublepeak in the macromolecular region which could reflect at least two types of immune complexes. The first peak could be complexes of a size corresponding to > 19S and the second peak of a size between 7S and 19S.
In order to study whether the precipitation of 1251 SpA in the macromolecular region was due to immune complexes the influence of highly purified Clq was investigated. 5 ,Lg Clq was added to 500 V.1 of each fraction of the SLE patient serum investigated above (Fig. 6 ) and incubated for 1 hour at room temperature. The degree of precipitation of added 1251 SpA was then studied. As shown in Fig. 6 there was a distinct inhibition of 1251 SpA precipitation in the presence of Clq. These findings might suggest that Clq reacts with present immune complexes and probably by steric hindrance prevents the binding of 1251 SpA.
Further support for the concept that the 125I SpA precipitating activity in the macromolecular region corresponds to immune complexes formed in vitro was provided by testing tetanus-antitetanus complexes. There was no significant precipitation of 1251 SpA in the macromolecular fractions of an antitetanus serum separated according to the gel chromatography procedure B. A significant increase of 125I SpA precipitation was obtained in the corresponding fractions of the same serum after addition of tetanus according to the procedure described above. In order to see if the adoptive immune complex assay could be of clinical use, screening was done on patients with different disorders, selected for the high probability of raised immune complex levels in their sera. The precipitation activity in the assay is expressed in corresponding agg IgG equivalent, mg/l. In Fig. 7 a representative calibration curve in the standardized macromolecular solution is presented.
The upper limit of precipitating activity for 18 normal sera was less than 4 ml/l and results were only considered abnormal and positive if above this value. Fig. 8 In a study of sera from 9 patients with metastatic tumours of different forms, only one with breast adenocarcinoma together with liver and pulmonary metastases had detectable immune aggregates, 27 mg/l. No patient with terminal ileitis was positive in the immune complex assay while one out of 4 patients with scleroderma was.
Discussion
Circulating immune complexes have been detected by a variety of methods. These methods have taken advantage of the fact that immune complexes are macromolecular substances which can be separated from other serum proteins. Both chromatographic separation (Soothill and Hendrickse, 1967) and ultracentrifugation in sucrose density gradients (Kunkel and others, 1961) are based on that principle. A more widely used indirect method is based on the anticomplementary activity of immune complexes (Kohler and Bensel, 1969) . More specific methods use the property of direct interaction with complexed antibody. The Clq component ofcomplement, which is known to precipitate soluble immune complexes and agg IgG, have been used in a gel diffusion to detect circulating immune complexes in the sera of patients with SLE and other hypocomplementary states. This method is rather insensitive and besides low molecular weight substances of unknown nature exist which also react with Clq giving falsepositive results (Agnello, Winchester, and Kunkel, 1970) . By radiolabelling of Clq and studying the precipitation of immune complexes in PEG solution, as little as 50 mg agg IgG/I serum could be detected (Nydegger and others, 1974) . The sensitivity of this method is high but the accuracy may be inadequate since it is necessary to heat inactive sera before assaying. This procedure leads to a considerable degree of aggregation of both IgG and IgM and as Clq reacts with both, false-positive results proportional to the immunglobulin level may be suspected (Johnson, Mowbray, and Porter, 1975) . The relative instability of purified, radiolabelled Clq may also be a problem.
These experiments were done to explore the possibility of increasing the sensitivity of SpA-IgG reactions by polymer enhancement. SpA, which is a cell wall constituent of Staph. aureus, reacts with the (Hellsing, 1966) . The same effect was obtained with 1251 SpA-agg IgG complexes. This enhancement of the precipitation by polymers has been explained as a steric exclusion of the complexes from the domain of the polysaccharides (Laurent, 1963 (Heimer and Levin, 1966) . Results of the present investigation show that rheumatoid factors also may react with 1251 SpA-IgG complexes and this probably explains why some sera with rheumatoid factor activity gave a 125I SpA precipitation in spite of the competition with mon IgG. Clq binds to the Fc part of IgA and was found to interfere with the 1251 SpA-agg IgG reaction, probably due to steric hindrance.
Considering the interference of these serum factors, it was necessary to accurately measure the immune complex level in serum to separate mon IgG from immune aggregates and to eliminate Clq. Sera were fractionated by gel chromatography (G200) and the void volumes were heat inactivated at 56°C for 30 minutes to destroy Clq and assayed for the contents of immune complexes according to the 1251 SpA-PEG procedure. In order to have a test suitable for practical clinical use it was essential to speed the fractionating rate up as it was most of the time consuming part of the assay. This was achieved by running small columns (0*9 x 30 cm) of G200. The chromatography procedure will be a minor problem when automatic chromatography apparatus is used to a greater extent.
The immune complex assay was applied to the study of fresh sera from patients with SLE and rheumatoid arthritis. The results indicated a high frequency of immune complexes in these disorders. 58 % of the SLE patients had a precipitating activity in serum ranging from 12-80 mg/I, and 42% of the patients with rheumatoid arthritis with a range of 5-50 mg/l. The results are consistent with the observations of other investigators, who have also observed increased frequency of immune complexes in sera of patients with these diseases. However, depending on the method used there is a wide variation in the frequency observed and it is difficult to make a proper comparative analysis (Agnello and others, 1971; Nydegger and others, 1974; Norberg, 1974) . The nature of IgG complexes found in rheumatoid arthritis sera have been discussed and there is support that the dominant constituents are IgGrheumatoid factor complexes (Schrohenloher, 1966) . It is likely that DNA-anti-DNA complexes are involved in the pathogenesis of SLE (Harbeck and others, 1973) . None of the normal individuals had immune aggregates estimated as precipitating activity exceeding 4 mg/ml. It is not known if the small amounts of IgG complexes detectable in sera of healthy individuals reflect a true normal level of immune complexes.
In our study 8 patients with terminal ileitis did not have increased levels of IgG complexes compared to the reference group. These results are at variance with those of other investigators (Doe, Booth, and Brown, 1973) but there are several possible explanations for these differences. The nature of immune complexes in terminal ileitis have not been identified but alimentary proteins as an exogenous source of antigens have been suggested. Both the time relation of blood sampling to food intake and the condition of the small intestine may influence the frequency of positive reactions.
The possible presence of immune complexes in sera of patients with scleroderma does not seem to have been investigated previously. The serum from one of the patients with this disease was positive in our immune complex assay and it cannot be excluded that immune complexes may be involved in the pathogenesis of this disorder.
Considerable evidence indicates that human tumours are antigenic for their hosts and are eliciting humoral immune response (Hellstrom, Hellstr6m, and Pierce, 1968) . Circulating antibody can be shown when the antigenic mass is small but during periods of rapid growth and in the presence of a large mass of tumour tissues no free antibody is detectable (Ambrose, Andersson, and Coggin, 1971 ). When sera from 9 patients with different forms of cancer were investigated one patient with a metastatic breast adenocarcinoma had an increased amount of 1251 SpA-precipitable material in the macromolecular region. Only a few investigators have, in selected and isolated cases with metastasing tumours, directly shown immune complexes in sera (Ludwig and Cusumano, 1974) . These results indicate a low frequency of detectable immune aggregates in sera of cancer patients.
The immune complex assay using 1251 SpA is not capable of detecting all forms of immune complexes is serum. SpA reacts with the Fc part of human IgG subclasses 1, 2, and 4 (Kronwall and Williams, 1969) , giving the method a specificity for immune aggregates composed of these subclasses only. 
